stella
beta
ELEVATE High-Risk PCI Pivotal Study — Stella
Home
/
High-Risk Percutaneous Coronary Intervention (High-risk PCI)
/
View on ClinicalTrials.gov
Recruiting
Back to High-Risk Percutaneous Coronary Intervention (High-risk PCI) trials
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(28 sites)
United States
HonorHealth Scottsdale Shea Medical Center, Scottsdale, Arizona
University of California at San Francisco Medical Center, San Francisco, California
Tampa General/USF, Tampa, Florida
Wellstar Health System, Marietta, Georgia
University of Chicago Medical Center, Chicago, Illinois
St. Elizabeth Healthcare, Edgewood, Kentucky
Massachusetts General Hospital, Boston, Massachusetts
Brigham & Women's Hospital, Boston, Massachusetts
Boston Medical Center, Boston, Massachusetts
Beth Israel Deaconess Medical Center, Boston, Massachusetts
UMass Memorial Medical Center, Worcester, Massachusetts
Henry Ford Health, Detroit, Michigan
Minneapolis Heart Institute, Minneapolis, Minnesota
St. Luke's Hospital of Kansas City, Kansas City, Missouri
Atlantic Health System, Morristown, New Jersey
Robert Wood Johnson University Hospital, New Brunswick, New Jersey
Northwell- South Shore University Hospital, Bay Shore, New York
Maimonides Health, Brooklyn, New York
Buffalo General Medical Center, Buffalo, New York
North Shore University Hospital, Manhasset, New York
NYU Langone/Bellevue/Long Island, New York, New York
Mount Sinai, New York, New York
Columbia University Medical Center/NYPH, New York, New York
Weill Cornell Medical Center, New York, New York
Northwell- Lenox Hill, New York, New York
TriStar Centennial Medical Center, Nashville, Tennessee
Inova Schar Heart & Vascular, Falls Church, Virginia
Advocate Aurora Health Research Institute- St. Luke's Medical Center, Milwaukee, Wisconsin